|
Volumn , Issue , 2006, Pages 40-47
|
The right to a trial: Should dying patients have access to experimental drugs?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG;
ACQUIRED IMMUNE DEFICIENCY SYNDROME;
ARTICLE;
CLINICAL TRIAL;
DRUG APPROVAL;
DRUG INDUSTRY;
DRUG LEGISLATION;
ECONOMICS;
ETHICS;
FOOD AND DRUG ADMINISTRATION;
HISTORY;
LEGAL ASPECT;
MANPOWER;
MEDICAL ETHICS;
METHODOLOGY;
NEOPLASM;
RESEARCH;
RESEARCH ETHICS;
STANDARD;
STATISTICS;
UNITED STATES;
UTILIZATION REVIEW;
ACQUIRED IMMUNODEFICIENCY SYNDROME;
CLINICAL TRIALS;
DRUG APPROVAL;
DRUG INDUSTRY;
ETHICS, MEDICAL;
ETHICS, PHARMACY;
ETHICS, RESEARCH;
HISTORY, 20TH CENTURY;
HISTORY, 21ST CENTURY;
LEGISLATION, DRUG;
NEOPLASMS;
PHARMACEUTICAL PREPARATIONS;
RESEARCH;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 34547209359
PISSN: 0028792X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (8)
|
References (0)
|